Vida Ventures II, LLC 4
4 · Aktis Oncology, Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Vida Ventures II, LLC
10% Owner
Transactions
- Conversion
Series A Redeemable Convertible Preferred Stock
[F4][F3]2026-01-12−411,750→ 0 total(indirect: See Footnote)→ Common Stock (108,229 underlying) - Conversion
Common Stock
[F1][F2]2026-01-12+4,859,370→ 4,859,370 total(indirect: See Footnote) - Purchase
Common Stock
[F2]2026-01-12$18.00/sh+812,455$14,624,190→ 5,671,825 total(indirect: See Footnote) - Conversion
Common Stock
[F1][F3]2026-01-12+134,842→ 134,842 total(indirect: See Footnote) - Purchase
Common Stock
[F3]2026-01-12$18.00/sh+22,545$405,810→ 157,387 total(indirect: See Footnote) - Conversion
Series A Redeemable Convertible Preferred Stock
[F4][F2]2026-01-12−14,838,250→ 0 total(indirect: See Footnote)→ Common Stock (3,900,284 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
[F5][F2]2026-01-12−3,648,750→ 0 total(indirect: See Footnote)→ Common Stock (959,086 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
[F5][F3]2026-01-12−101,250→ 0 total(indirect: See Footnote)→ Common Stock (26,613 underlying)
Footnotes (5)
- [F1]Represents shares of the Issuer's Common Stock received upon conversion of shares of the Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock on a 3.8044-for-1 basis without payment of additional consideration.
- [F2]These shares are held by Vida Ventures II, LLC ("VV II"). VV Manager II, LLC ("VVM II") is the manager of VV II and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and Helen Kim, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein.
- [F3]These shares are held by Vida Ventures II-A, LLC ("VV II-A"). VVM II is the manager of VV II-A and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II-A. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and Helen Kim, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II-A and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein.
- [F4]The Series A Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 3.8044-for-1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock without payment of additional consideration.
- [F5]The Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 3.8044-for-1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock without payment of additional consideration.